My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 237

    1.

    2-(8-hydroxy-6-methoxy-1-oxo-1h-2-benzopyran-3-yl) propionic acid, an inhibitor of angiogenesis, ameliorates renal alterations in obese type 2 diabetic mice.

    Ichinose K, Maeshima Y, Yamamoto Y, Kinomura M, Hirokoshi K, Kitayama H, Takazawa Y, Sugiyama H, Yamasaki Y, Agata N, Makino H.

    Diabetes. 2006 May;55(5):1232-42.PMID: 16644677 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.

    Ichinose K, Maeshima Y, Yamamoto Y, Kitayama H, Takazawa Y, Hirokoshi K, Sugiyama H, Yamasaki Y, Eguchi K, Makino H.

    Diabetes. 2005 Oct;54(10):2891-903. Erratum in: Diabetes. 2006 Sep;55(9):2665. PMID: 16186390 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody.

    Flyvbjerg A, Dagnaes-Hansen F, De Vriese AS, Schrijvers BF, Tilton RG, Rasch R.

    Diabetes. 2002 Oct;51(10):3090-4.PMID: 12351452 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Vasohibin-1, a negative feedback regulator of angiogenesis, ameliorates renal alterations in a mouse model of diabetic nephropathy.

    Nasu T, Maeshima Y, Kinomura M, Hirokoshi-Kawahara K, Tanabe K, Sugiyama H, Sonoda H, Sato Y, Makino H.

    Diabetes. 2009 Oct;58(10):2365-75. Epub 2009 Jul 8.PMID: 19587360 [PubMed - indexed for MEDLINE]Related articles

    5.

    Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.

    Koya D, Haneda M, Nakagawa H, Isshiki K, Sato H, Maeda S, Sugimoto T, Yasuda H, Kashiwagi A, Ways DK, King GL, Kikkawa R.

    FASEB J. 2000 Mar;14(3):439-47.PMID: 10698958 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice.

    Chow FY, Nikolic-Paterson DJ, Ma FY, Ozols E, Rollins BJ, Tesch GH.

    Diabetologia. 2007 Feb;50(2):471-80. Epub 2006 Dec 12.PMID: 17160673 [PubMed - indexed for MEDLINE]Related articles

    7.

    Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy.

    Cohen MP, Chen S, Ziyadeh FN, Shea E, Hud EA, Lautenslager GT, Shearman CW.

    Kidney Int. 2005 Oct;68(4):1554-61.PMID: 16164632 [PubMed - indexed for MEDLINE]Related articles

    8.

    SMP-534 ameliorates progression of glomerular fibrosis and urinary albumin in diabetic db/db mice.

    Sugaru E, Nakagawa T, Ono-Kishino M, Nagamine J, Tokunaga T, Kitoh M, Hume WE, Nagata R, Taiji M.

    Am J Physiol Renal Physiol. 2006 Apr;290(4):F813-20. Epub 2005 Nov 8.PMID: 16278277 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Urocortin ameliorates diabetic nephropathy in obese db/db mice.

    Li X, Hu J, Zhang R, Sun X, Zhang Q, Guan X, Chen J, Zhu Q, Li S.

    Br J Pharmacol. 2008 Jul;154(5):1025-34. Epub 2008 Apr 21.PMID: 18587447 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury.

    Chow F, Ozols E, Nikolic-Paterson DJ, Atkins RC, Tesch GH.

    Kidney Int. 2004 Jan;65(1):116-28.PMID: 14675042 [PubMed - indexed for MEDLINE]Related articles

    11.

    Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy.

    Yamamoto Y, Maeshima Y, Kitayama H, Kitamura S, Takazawa Y, Sugiyama H, Yamasaki Y, Makino H.

    Diabetes. 2004 Jul;53(7):1831-40.PMID: 15220208 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency.

    Cohen MP, Lautenslager GT, Hud E, Shea E, Wang A, Chen S, Shearman CW.

    Am J Physiol Renal Physiol. 2007 Feb;292(2):F789-95. Epub 2006 Oct 3.PMID: 17018845 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Renoprotective effect of COMP-angiopoietin-1 in db/db mice with type 2 diabetes.

    Lee S, Kim W, Moon SO, Sung MJ, Kim DH, Kang KP, Jang KY, Lee SY, Park BH, Koh GY, Park SK.

    Nephrol Dial Transplant. 2007 Feb;22(2):396-408. Epub 2006 Nov 3.PMID: 17085463 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.

    Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K.

    Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):8015-20.PMID: 10859350 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Long-term treatment of glucagon-like peptide-1 analog exendin-4 ameliorates diabetic nephropathy through improving metabolic anomalies in db/db mice.

    Park CW, Kim HW, Ko SH, Lim JH, Ryu GR, Chung HW, Han SW, Shin SJ, Bang BK, Breyer MD, Chang YS.

    J Am Soc Nephrol. 2007 Apr;18(4):1227-38. Epub 2007 Mar 14.PMID: 17360951 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Galectin-9 inhibits glomerular hypertrophy in db/db diabetic mice via cell-cycle-dependent mechanisms.

    Baba M, Wada J, Eguchi J, Hashimoto I, Okada T, Yasuhara A, Shikata K, Kanwar YS, Makino H.

    J Am Soc Nephrol. 2005 Nov;16(11):3222-34. Epub 2005 Sep 21.PMID: 16177004 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Mizoribine reduces renal injury and macrophage infiltration in non-insulin-dependent diabetic rats.

    Kikuchi Y, Imakiire T, Yamada M, Saigusa T, Hyodo T, Hyodo N, Suzuki S, Miura S.

    Nephrol Dial Transplant. 2005 Aug;20(8):1573-81. Epub 2005 May 19.PMID: 15905195 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice.

    Jia ZH, Liu ZH, Zheng JM, Zeng CH, Li LS.

    Exp Clin Endocrinol Diabetes. 2007 Oct;115(9):571-6.PMID: 17943690 [PubMed - indexed for MEDLINE]Related articles

    19.

    Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes.

    Wang Z, Jiang T, Li J, Proctor G, McManaman JL, Lucia S, Chua S, Levi M.

    Diabetes. 2005 Aug;54(8):2328-35.PMID: 16046298 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na(+)-glucose cotransporter inhibitor T-1095.

    Arakawa K, Ishihara T, Oku A, Nawano M, Ueta K, Kitamura K, Matsumoto M, Saito A.

    Br J Pharmacol. 2001 Jan;132(2):578-86.PMID: 11159708 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity